Pretreatment Found to Reduce Stages of Mohs Surgery for Basal Cell Carcinoma
A retrospective study evaluated the effect of 5% imiquimod prior to Mohs surgery in patients with basal cell carcinoma.
Skin Cancer
Racial Disparities in Skin Cancer Diagnosis, Prognosis, and Treatment
How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.
Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Dermatologic Adverse Events With Immune Checkpoint Inhibitors in Metastatic Melanoma
Female patients showed an enhanced rate of dermatologic adverse events with immune checkpoint inhibitor therapy for metastatic melanoma.
Real-World Data Finds an Overall Decrease in Pediatric Melanoma Diagnoses in the United States
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
Topical Remetinostat Reduces Disease Burden in Patients With Basal Cell Carcinoma
Remetinostat produced a complete response in 17 of 33 tumors.
Real-World Data Finds an Overall Decrease in Pediatric Melanoma Diagnoses in the United States
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors
Response endpoints were not strongly correlated with overall survival at the trial level.
Ipilimumab Plus Nivolumab Improves Survival in Melanoma With Brain Metastases
Combination ipilimumab and nivolumab reduced the risk of death by 56% when compared with fotemustine monotherapy.
Cemiplimab Deemed Active, Safe After HHIs in Locally Advanced Basal Cell Carcinoma
Phase 2 trial results supported the approval of cemiplimab for this patient group.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...